Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells
- 24 April 2009
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 53 (5) , 253-264
- https://doi.org/10.1111/j.1600-0609.1994.tb01317.x
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Mutations in Jewish patients with Gaucher diseaseBlood, 1992
- Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.Proceedings of the National Academy of Sciences, 1991
- Heterogeneity of Mutations in the Acid β-Glucosidase Gene of Gaucher Disease PatientsDNA and Cell Biology, 1991
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989
- Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.Proceedings of the National Academy of Sciences, 1988
- BENEFICIAL EFFECT OF PRE-TRANSPLANT SPLENECTOMY ON DISPLACEMENT BONE MARROW TRANSPLANTATION FOR GAUCHER'S SYNDROMEThe Lancet, 1987
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- Type 2 and type 3 Gaucher disease: A morphological and biochemical studyAnnals of Neurology, 1986
- Bone-Marrow Transplantation in Severe Gaucher's DiseaseNew England Journal of Medicine, 1984
- Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's diseaseBiochemical and Biophysical Research Communications, 1965